Discontinued — last reported Q3 '25

Equity

Common Stock

Idexx Laboratories Common Stock remained flat by 0.0% to 120M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 120M to 120M. Over 5 years (FY 2020 to FY 2025), Common Stock shows an upward trend with a 62.3% CAGR.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ3 2025

How to read this metric

An increase indicates the issuance of new shares, which may dilute existing shareholders, while a stable balance indicates no new equity financing.

Detailed definition

This represents the aggregate par value of all common shares issued and outstanding. It is the foundational equity layer...

Peer comparison

Standard equity line item for all publicly traded companies.

Metric ID: common_stock

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value120M120M10.7M120M120M120M10.7M120M120M120M10.8M120M120M120M10.8M120M120M120M120M120M
QoQ Change+0.0%-91.1%>999%+0.0%+0.0%-91.1%>999%+0.0%+0.0%-91.0%>999%+0.0%+0.0%-91.0%>999%+0.0%+0.0%+0.0%+0.0%
YoY Change+0.0%+0.0%+0.3%+0.0%+0.0%+0.0%+0.3%+0.0%+0.0%+0.0%+0.3%+0.0%+0.0%+0.0%>999%+0.0%
Range10.7M120M
CAGR+0.0%
Avg YoY Growth+63.4%
Median YoY Growth+0.0%
Current Streak5 quarters growth

Frequently Asked Questions

What is Idexx Laboratories's common stock?
Idexx Laboratories (IDXX) reported common stock of 120M in Q1 2026.
How has Idexx Laboratories's common stock changed year-over-year?
Idexx Laboratories's common stock decreased by 0.0% year-over-year, from 120M to 120M.
What is the long-term trend for Idexx Laboratories's common stock?
Over 5 years (2020 to 2025), Idexx Laboratories's common stock has grown at a 62.3% compound annual growth rate (CAGR), from 10.6M to 120M.
What does common stock mean?
The total par value of all common shares issued to shareholders.